These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Climatic and socio-economic factors supporting the co-circulation of dengue, Zika and chikungunya in three different ecosystems in Colombia. Morgan J; Strode C; Salcedo-Sora JE PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009259. PubMed ID: 33705409 [TBL] [Abstract][Full Text] [Related]
48. Dengue research opportunities in the Americas. Laughlin CA; Morens DM; Cassetti MC; Costero-Saint Denis A; San Martin JL; Whitehead SS; Fauci AS J Infect Dis; 2012 Oct; 206(7):1121-7. PubMed ID: 22782946 [TBL] [Abstract][Full Text] [Related]
49. Global situation of dengue and dengue haemorrhagic fever, and its emergence in the Americas. Pinheiro FP; Corber SJ World Health Stat Q; 1997; 50(3-4):161-9. PubMed ID: 9477544 [TBL] [Abstract][Full Text] [Related]
50. Assessing dengue vaccination impact: Model challenges and future directions. Recker M; Vannice K; Hombach J; Jit M; Simmons CP Vaccine; 2016 Aug; 34(38):4461-4465. PubMed ID: 27461457 [TBL] [Abstract][Full Text] [Related]
51. Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease. Hadinegoro SR; Arredondo-García JL; Capeding MR; Deseda C; Chotpitayasunondh T; Dietze R; Muhammad Ismail HI; Reynales H; Limkittikul K; Rivera-Medina DM; Tran HN; Bouckenooghe A; Chansinghakul D; Cortés M; Fanouillere K; Forrat R; Frago C; Gailhardou S; Jackson N; Noriega F; Plennevaux E; Wartel TA; Zambrano B; Saville M; N Engl J Med; 2015 Sep; 373(13):1195-206. PubMed ID: 26214039 [TBL] [Abstract][Full Text] [Related]
52. Changes in the dynamics of dengue incidence in South and Central America are possibly due to cross-population immunity after Zika virus epidemics. Mugabe VA; Borja LS; Cardoso CW; Weaver SC; Reis MG; Kitron U; Ribeiro GS Trop Med Int Health; 2021 Mar; 26(3):272-280. PubMed ID: 33190402 [TBL] [Abstract][Full Text] [Related]
53. [Dengue in the Americas. A problem of regional health]. Gómez-Dantés H Salud Publica Mex; 1991; 33(4):347-55. PubMed ID: 1948410 [TBL] [Abstract][Full Text] [Related]
54. Exploring the role of a recently licensed dengue vaccine in Australian travellers. Thevarajan I; Torresi J; Simmons C Med J Aust; 2020 Feb; 212(3):102-103.e1. PubMed ID: 31909484 [No Abstract] [Full Text] [Related]
58. Analysis of the spatial distribution of scientific publications regarding vector-borne diseases related to climate variability in South America. López MS; Müller GV; Sione WF Spat Spatiotemporal Epidemiol; 2018 Aug; 26():35-93. PubMed ID: 30390933 [TBL] [Abstract][Full Text] [Related]
59. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial. Capeding MR; Tran NH; Hadinegoro SR; Ismail HI; Chotpitayasunondh T; Chua MN; Luong CQ; Rusmil K; Wirawan DN; Nallusamy R; Pitisuttithum P; Thisyakorn U; Yoon IK; van der Vliet D; Langevin E; Laot T; Hutagalung Y; Frago C; Boaz M; Wartel TA; Tornieporth NG; Saville M; Bouckenooghe A; Lancet; 2014 Oct; 384(9951):1358-65. PubMed ID: 25018116 [TBL] [Abstract][Full Text] [Related]